These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7416544)

  • 1. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
    Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activated coagulation time during extracorporeal circulation: useful for reducing the use of homologous blood?].
    Brandi LS; Benedetti M; Russo V; Grana M; Mosca F
    Minerva Anestesiol; 1984 Apr; 50(4):127-32. PubMed ID: 6472644
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin dosage in extracorporeal circulation and its neutralization.
    Nyman D; Thurnherr N; Duckert F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):102-4. PubMed ID: 1118825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemorrhages during cardiac surgery with extracorporeal circulation].
    Gascon P; Daussy M; Daumet P
    Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):323-7. PubMed ID: 5618385
    [No Abstract]   [Full Text] [Related]  

  • 8. [Method of control of the artificial heparinization of blood].
    Iunovidova LI; Savina ME; Kukaeva EA
    Lab Delo; 1985; (11):657-9. PubMed ID: 2417016
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with activated clotting time (ACT) controlled heparinization in open heart surgery.
    Albrechtsen OK; Stenbjerg S; Berg E
    Thorac Cardiovasc Surg; 1982 Apr; 30(2):109-12. PubMed ID: 6179241
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin level determination during extracorporeal circulation in open heart surgery].
    Binsack T; Hiller E; Pallast M; Welz A
    Fortschr Med; 1983 Dec; 101(46):2138-41. PubMed ID: 6662465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin rebound. Studies in patients and volunteers.
    Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
    J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
    Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
    Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparinization--protaminization control by activated clotting time with improved postoperative hemostasis].
    Lubliner J; Barak J; Yakirevich V; Vidne BA
    Harefuah; 1984 Jul; 107(1-2):4-6. PubMed ID: 6479745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum heparin concentration during extracorporeal circulation].
    Neef H; Pauer HD
    Thoraxchir Vask Chir; 1970 Dec; 18(6):497-502. PubMed ID: 5275549
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood coagulation studies and extracorporeal circulation in man.
    Thurnherr N
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW; Runne WC; Sixma JJ; Zimmerman AN
    J Thorac Cardiovasc Surg; 1974 Jul; 68(1):59-65. PubMed ID: 4834066
    [No Abstract]   [Full Text] [Related]  

  • 20. Individual responses to heparinization for extracorporeal circulation.
    Friesen RH; Clement AJ
    J Thorac Cardiovasc Surg; 1976 Dec; 72(6):875-9. PubMed ID: 994537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.